CYP26B1 and neoplasm: The mean survival for the CYP26B1 negative/weak/moderate group (n = 564) was 119 months (95%CI = 111–128 months) whereas the mean survival for CYP26B1 strong tumours (n = 58) was 80 months (95%CI = 60–101 months).